Co-Authors
This is a "connection" page, showing publications co-authored by Catherine Hogan and Natasha Garamani.
Connection Strength
1.292
-
High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease. Clin Infect Dis. 2021 05 04; 72(9):e291-e295.
Score: 0.236
-
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens. J Clin Microbiol. 2020 Jul 23; 58(8).
Score: 0.223
-
Retrospective Screening for SARS-CoV-2 RNA in California, USA, Late 2019. Emerg Infect Dis. 2020 Oct; 26(10):2487-2488.
Score: 0.223
-
Five-minute point-of-care testing for SARS-CoV-2: Not there yet. J Clin Virol. 2020 07; 128:104410.
Score: 0.220
-
Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2. J Clin Virol. 2020 06; 127:104383.
Score: 0.220
-
Combined SARS-CoV-2 nucleic acid amplification testing and respiratory virus panel RT-PCR on the Hologic Panther Fusion system. J Clin Virol. 2021 05; 138:104792.
Score: 0.058
-
Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA. J Appl Lab Med. 2020 11 01; 5(6):1307-1312.
Score: 0.057
-
Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2. J Clin Virol. 2020 08; 129:104427.
Score: 0.055